Cardiac Emergencies Perspective

 
 
  • Preventing Heart Failure Post-Myocardial Infarction Although heart failure is a common complication of myocardial infarction, prognostic tools and new therapies can help manage the condition. Here are some key facts.
  • The Future of Therapeutic Hypothermia for Stroke Renewed interest and recent data suggest that hypothermia may be neuroprotective in patients suffering from stroke.
  • Diagnosis of Hypertrophic Cardiomyopathy: What Every Cardiologist Needs to Know Although it is the most common inherited monogenic cardiac disorder, affecting up to 0.5% of the population, there is a gap in the recognition of this condition.
  • 'Cardio-COVID': Amal Mattu on COVID-19 and Matters of the Heart Dr Mattu discusses how to approach the treatment of cardiac complications in patients with COVID-19 in the emergency department.
  • 'COVID Calculus' Is Changing Medicine 'COVID calculus' is about balancing risk and benefit in the whole hospital system, and it's getting worse as the epidemic worsens. But it's not all bad, says F. Perry Wilson.
  • Malpractice Case: Be Aware When Follow-up Requires Extra Steps When patient cases get complicated and assistance is offered, physicians are best advised to reach out for help. Failure to do so can result in litigation if something should go wrong.
  • Controversies in Cardiogenic Shock   Dr Ileana Piña discusses controversies surrounding cardiogenic shock, including data presented at the AHA Scientific Sessions 2019.
  • Entering the TWILIGHT Zone of DAPT Duration   Experts from the Mayo Clinic discuss the impact of TWILIGHT, a comparison of ticagrelor monotherapy vs dual-antiplatelet therapy in post-PCI patients.
  • Epinephrine for Cardiac Arrest: Guidance Inflated? Dr Amal Mattu reviews the AHA update on cardiac life support and questions the current recommendations for using epinephrine in cardiac arrest.
  • Chronic Heart Failure: Old Habits   Cardiologists call upon their colleagues to adapt newer therapies for heart failure patients, as recommended by the latest guidelines.
  • Supraglottic Airway Device or Tracheal Intubation in OHCA? Is a supraglottic airway device superior to tracheal intubation as the initial advanced airway management strategy in adults with nontraumatic out-of-hospital cardiac arrest?
  • The War on Shock: Is Industry Leading the Charge? Protocols for patients in cardiogenic shock encourage use of mechanical circulatory support and play down palliative care, despite limited supporting data, writes interventional cardiologist Jaya Mallidi.
  • ECG Challenge: A Post–Cardiac Arrest Pattern As part of his recovery from cardiac arrest, a 69-year-old man is put under a cooling blanket. See if you can spot a signature wave on his ECG.
  • Heart Doc Writes About His 'Front-Row Seat' in Medicine   Cardiologist Haider Warraich discusses his prolific writing career in this episode of Medscape One-on-One with Eric Topol.
  • Mandrola's Top 10 Cardiology Stories of 2019 It's probably no surprise that ISCHEMIA and the EXCEL controversy make John Mandrola's annual list for 2019. He also found good news in heart failure and has words of caution for TAVR expansion.
  • Cardiology 2019: Top Trials in Review   'It's like we're in the '90s again.' Drs Gibson and Harrington review top cardiology trials on revascularization, lipid management, and antithrombotics in part 1 of their annual wrap-up.
  • AI May Help Doctors Be Doctors (and Better Ones, Too)   Cardiologists and bioengineers work together at the Mayo Clinic to develop new innovations in artificial intelligence.
  • Impella vs IABP: Urgent Need for RCT   An RCT data void on Impella vs intra-aortic balloon pump led to two observational studies at AHA showing worse outcomes for Impella. John Mandrola asks the investigators from one study, 'What now?'
  • Chronic Heart Failure: Looks Can Be Deceiving   Heart failure specialists discuss factors that contribute to adverse outcomes in their patients, including mechanisms that underlie the condition.
  • John Spertus, MD, on the Practice-Changing ISCHEMIA Trial   The ISCHEMIA investigator discusses the implications of the gasp-inducing trial comparing an invasive vs conservative medical therapy strategy in patents with stable ischemic heart disease.